SCHEMBL20746450

SCHEMBL20746450

Cc1ccc(S(=O)(=O)OC(CO)CN(C)C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.42
AGER Q15109 1/20 0.41
ATM Q13315 1/20 0.39
CYP2C19 P33261 2/20 0.38
CYP1A2 P05177 1/20 0.38
CA2 P00918 2/20 0.37
EGFR P00533 1/20 0.37
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
MAPT P10636 1/20 0.37
MCOLN3 Q8TDD5 1/20 0.37
ALOX15 P16050 1/20 0.36
GAA P10253 1/20 0.36
PPARG P37231 1/20 0.36
DHODH Q02127 1/20 0.35
ALDH1A1 P00352 3/20 0.35
CA1 P00915 1/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22656000 1.00 KMT2A (0.42) KMT2AAGERATMCYP2C19CYP1A2
SCHEMBL20746510 1.00 KMT2A (0.42) KMT2AAGERATMCYP2C19CYP1A2
SCHEMBL7806253 0.87 GAA (0.43) KMT2AAGERCYP2C19CA2CA12
Acetone SCHEMBL11517974 0.83 ALDH1A1 (0.41) KMT2AAGERCYP2C19CA2GAA
SCHEMBL21803204 0.83 STAT3 (0.40) KMT2AAGERCYP2C19CA2CA12
SCHEMBL11264990 0.81 GAA (0.38) KMT2AAGERCYP2C19CA2CA12
SCHEMBL7147511 0.81 CA2 (0.40) KMT2AAGERCYP2C19CYP1A2CA2
SCHEMBL23395839 0.80 CA2 (0.45) KMT2AAGERCYP2C19CA2CA12
SCHEMBL3446919 0.80 STAT3 (0.41) KMT2AAGERCYP2C19CA2CA12
SCHEMBL29245112 0.80 CA2 (0.45) KMT2AAGERCYP2C19CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3668878-A1 COMPOUNDS THAT INHIBIT MCL-1 PROTEIN Amgen Inc. (US) 2020-06-24 EP disclosed
WO-2019036575-A1 COMPOUNDS THAT INHIBIT MCL-1 PROTEIN AMGEN INC. (US) 2019-02-21 WO disclosed